Walleye Trading LLC Vaxcyte, Inc. Transaction History

Walleye Trading LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$45.35 - $63.41 $305,704 - $427,446	6,741 New	6,741 $423,000
Q2 2023 Aug 14, 2023	BUY	$34.66 - $54.07 $95,800 - $149,449	2,764 New	2,764 $138,000
Q4 2022 Feb 14, 2023	BUY	$20.58 - $47.95 $300,961 - $701,220	14,624 Added 161.72%	23,667 $1.13 Million
Q3 2022 Nov 14, 2022	BUY	$21.69 - $28.53 $196,142 - $257,996	9,043 New	9,043 $217,000

351

130M

731K

430K

Ticker PCVX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,315,100
Market Cap $4.97B
Description
Vaxcyte, Inc., a clinical-stage biotechnology vaccine company, develops novel protein vaccines to prevent or treat bacterial infectious diseases. Its lead vaccine candidate is VAX-24, a 24-valent investigational pneumococcal conjugate vaccine that is in Phase 1/2 clinical trials to treat invasive pneumococcal disease and pneumonia. The company a...

Get notified when there are updates to the investment portfolio of Walleye Trading LLC, based on Form 13F filings with the SEC.

Stay updated on Walleye Trading LLC with notifications on news.